Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 13, 2017 - Issue 9
Submit an article Journal homepage
1,876
Views
25
CrossRef citations to date
0
Altmetric
Research Papers

Open-label phase I clinical trial of Ad5-EBOV in Africans in China

Lihua WuThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Zhe ZhangBeijing Institute of Biotechnology, Haidian District, Beijing, China
,
Hainv GaoThe Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China;Zhejiang University International Hospital, Xiacheng District, Hangzhou, Zhejiang, China
,
Yuhua LiNational Institutes for Food and Drug Control, Chongwen District, Beijing, China
,
Lihua HouBeijing Institute of Biotechnology, Haidian District, Beijing, China
,
Hangping YaoThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Shipo WuBeijing Institute of Biotechnology, Haidian District, Beijing, China
,
Jian LiuThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Ling WangNational Institutes for Food and Drug Control, Chongwen District, Beijing, China
,
You ZhaiThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Huilin OuThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Meihua LinThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Xiaoxin WuThe Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China;Zhejiang University International Hospital, Xiacheng District, Hangzhou, Zhejiang, China
,
Jingjing LiuNational Institutes for Food and Drug Control, Chongwen District, Beijing, China
,
Guanjing LangThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Qian XinThe General Hospital of People's Liberation Army, Beijing, China
,
Guolan WuThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Li LuoDepartment of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, Jiangsu, China
,
Pei LiuDepartment of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, Jiangsu, China
,
Jianzhong ShentuThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Nanping WuThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Jifang ShengThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Yunqing QiuThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China
,
Wei ChenBeijing Institute of Biotechnology, Haidian District, Beijing, ChinaCorrespondence[email protected]
&
Lanjuan LiThe First Affiliated Hospital, College of Medicine, Zhejiang University, Xiacheng District, Hangzhou, Zhejiang, China;The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Xiacheng District, Hangzhou, Zhejiang, China;Zhejiang University International Hospital, Xiacheng District, Hangzhou, Zhejiang, ChinaCorrespondence[email protected]
 show all
Pages 2078-2085 | Received 04 Apr 2017, Accepted 08 Jun 2017, Published online: 03 Aug 2017

References

  • Nanclares C, Kapetshi J, Lionetto F, de la Rosa O, Tamfun JJ, Alia M, Kobinger G, Bernasconi A. Ebola virus disease, democratic republic of the Congo, 2014. Emerg Infect Dis 2016; 22(9):1579-86; PMID:27533284; https://doi.org/10.3201/eid2209.160354
  • Hersey S, Martel LD, Jambai A, Keita S, Yoti Z, Meyer E, Seeman S, Bennett S, Ratto J, Morgan O, et al. Ebola Virus Disease–Sierra Leone and Guinea, August 2015. MMWR Morb Mortal Wkly Rep 2015; 64(35):981-4; PMID:26355422; https://doi.org/10.15585/mmwr.mm6435a6
  • Martins KA, Jahrling PB, Bavari S, Kuhn JH. Ebola virus disease candidate vaccines under evaluation in clinical trials. Expert Rev Vaccines 2016; 15(9):1101-12; PMID:27160784; https://doi.org/10.1080/14760584.2016.1187566
  • Ledgerwood JE, DeZure AD, Stanley DA, Coates EE, Novik L, Enama ME, Berkowitz NM, Hu Z, Joshi G, Ploquin A, et al. Chimpanzee adenovirus vector ebola vaccine. N Engl J Med 2017; 376(10):928-38; PMID:25426834; https://doi.org/10.1056/NEJMoa1410863
  • De Santis O, Audran R, Pothin E, Warpelin-Decrausaz L, Vallotton L, Wuerzner G, Cochet C, Estoppey D, Steiner-Monard V, Lonchampt S, et al. Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study. Lancet Infect Dis 2016; 16(3):311-20; PMID:26725450; https://doi.org/10.1016/S1473-3099(15)00486-7
  • Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keita S, De Clerck H, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371(15):1418-25; PMID:24738640; https://doi.org/10.1056/NEJMoa1404505
  • Zhu FC, Hou LH, Li JX, Wu SP, Liu P, Zhang GR, Hu YM, Meng FY, Xu JJ, Tang R, et al. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet 2015; 385(9984):2272-9; PMID:25817373; https://doi.org/10.1016/S0140-6736(15)60553-0
  • Ewer K, Rampling T, Venkatraman N, Bowyer G, Wright D, Lambe T, Imoukhuede EB, Payne R, Fehling SK, Strecker T, et al. A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA. N Engl J Med 2016; 374(17):1635-46; PMID:25629663; https://doi.org/10.1056/NEJMoa1411627
  • Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 386(9996):857-66; PMID:26248676; https://doi.org/10.1016/S0140-6736(15)61117-5
  • Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, Yerly S, Dayer JA, Kraehling V, Kasonta R, et al. Phase 1 Trials of rVSV Ebola vaccine in Africa and Europe. N Engl J Med 2016; 374(17):1647-60; PMID:25830326; https://doi.org/10.1056/NEJMoa1502924
  • Tapia MD, Sow SO, Lyke KE, Haidara FC, Diallo F, Doumbia M, Traore A, Coulibaly F, Kodio M, Onwuchekwa U, et al. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2016; 16(1):31-42; PMID:26546548; https://doi.org/10.1016/S1473-3099(15)00362-X
  • Huttner A, Dayer JA, Yerly S, Combescure C, Auderset F, Desmeules J, Eickmann M, Finckh A, Goncalves AR, Hooper JW, et al. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. Lancet Infect Dis 2015; 15(10):1156-66; PMID:26248510; https://doi.org/10.1016/S1473-3099(15)00154-1
  • Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, et al. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine 2010; 29(2):304-13; PMID:21034824; https://doi.org/10.1016/j.vaccine.2010.10.037
  • Sumida SM, Truitt DM, Kishko MG, Arthur JC, Jackson SS, Gorgone DA, Lifton MA, Koudstaal W, Pau MG, Kostense S, et al. Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors. J Virol 2004; 78(6):2666-73; PMID:14990686

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.